24 May 2013
Keywords: ipsen, filed, bsa, dysport, fda, france, says
Article | 10 December 2007
France's Ipsen says that it has submitted a Biologics License Application for Dysport for Injection, a botulinum neurotoxin type A
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 December 2007
17 December 2007
3 December 2007
© 2013 thepharmaletter.com